Hodgkin lymphoma (HL) in patients with HIV/AIDS is a challenging task because of the lack of established treatment and the need of meticulous attention to drug-drug interactions between highly active antiretroviral agents (HAART) and standard multi-agent chemotherapy. We report a case of recurrent HL in a patient, affected by HIV/AIDS and HCV-infection. The complex therapeutic management has been described; integrase inhibitors have shown a favorable interaction profile, allowing the completion of the chemotherapy regimen.
To cite this article
Hodgkin lymphoma in an HIV infected patient: relapses, poly-pathologies and complexity of the therapeutic management
Infectious Diseases & Tropical Medicine 2016; 2 (3): e316
Submission date: 15 Sep 2016
Revised on: 21 Sep 2016
Accepted on: 26 Sep 2016
Published online: 11 Oct 2016
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.